Caroline Baumal
Chief Tech/Sci/R&D Officer bei APELLIS PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Profil
Caroline Baumal is currently the Chief Medical Officer at Apellis Pharmaceuticals, Inc. and a Professor at New England Eye Center.
She holds a doctorate degree from the University of Toronto.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.01.2024 | 58 376 ( 0,05% ) | 3 Mio $ | 30.04.2024 |
Aktive Positionen von Caroline Baumal
| Unternehmen | Position | Beginn |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03.01.2023 |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Ausbildung von Caroline Baumal
| University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Health Services |
